EP 1390060 A2 20040225 - USE OF LP82 TO TREAT BODY WEIGHT DISORDERS
Title (en)
USE OF LP82 TO TREAT BODY WEIGHT DISORDERS
Title (de)
VERWENDUNG VON LP82 ZUR BEHANDLUNG VON STÖRUNGEN DES KÖRPERGEWICHTES
Title (fr)
UTILISATION DE LP82 POUR TRAITER LES PROBLEMES DE POIDS
Publication
Application
Priority
- US 0200498 W 20020115
- US 26423901 P 20010126
Abstract (en)
[origin: WO02058724A2] The present invention relates to a mammalian gene that is involved in the control of mammalian body weight. More specifically the present invention relates to methods of using compositions comprising LP82 polynucleotides, LP82 polypeptides, and/or LP82 antibodies for the prevention and/or treatment of mammalian body weight disorders, including obesity, cachexia, and anorexia.
IPC 1-7
A61K 38/19; A61K 39/395; A61K 48/00; A01K 67/027; A61P 3/04; A61P 3/06; A61P 3/10
IPC 8 full level
A01K 67/027 (2006.01); A61K 38/20 (2006.01); A61K 38/48 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); C12N 15/85 (2006.01); A61K 48/00 (2006.01)
CPC (source: EP)
A01K 67/0275 (2013.01); A61K 38/20 (2013.01); A61P 3/04 (2017.12); A61P 3/06 (2017.12); A61P 3/10 (2017.12); C12N 15/8509 (2013.01); A01K 2207/15 (2013.01); A01K 2217/00 (2013.01); A01K 2217/05 (2013.01); A01K 2227/105 (2013.01); A01K 2267/03 (2013.01); A01K 2267/0362 (2013.01); A61K 48/00 (2013.01)
Citation (search report)
See references of WO 02058724A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02058724 A2 20020801; WO 02058724 A3 20031218; WO 02058724 A8 20040521; EP 1390060 A2 20040225
DOCDB simple family (application)
US 0200498 W 20020115; EP 02720768 A 20020115